Elevance Health, Inc.
corporate_fare Company Profile
Elevance Health, Inc. (NYSE:ELV) is a publicly traded company in the Finance sector. Wiseek has independently scored 19 items for ELV at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 19 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for ELV spans 10-Q, 8-K, 10-K.
Recent high-impact activity:
- Elevance Sues Autism-Therapy Provider Over $160 Million in Alleged Fraud
- Elevance Q3 10-Q: EPS Up 17.9%, but Health Benefits Margin Compresses and 2027 Star Ratings Slip
- Elevance Beats Q3, Raises FY26 EPS Guidance to at Least $29.00
- Elevance Beats Q3 by $2.28 a Share, Lifts 2026 EPS Outlook to at Least $29
- Elevance Health Q2: Membership Slides 1.5%, CMS Risk Adjustment Matter Closed
Financial Snapshot
Short Interest & Short Volume
3.26 days to coverFINRA reported short interest of 4,544,947 shares in ELV as of the October 30, 2026 settlement, a 11.5% decrease from the prior period — about 3.3 days to cover at its recent average daily volume. On November 20, 2026, 59.9% of ELV volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.